Biljana Georgievska
Chief Commercial Officer
Biljana Georgievska has over 15 years extensive global experience in strategic and operations clinical research management, specializing in the development of clinical trials of novel therapeutic cancer therapies and Phase 1 healthy volunteer clinical trials. Her in-depth knowledge and understanding of the USA and Australian markets has been instrumental in her ability to form strong results-driven relationships with biotechnology and pharmaceutical clients.
Biljana’s customer-centric approach translates to best possible outcomes for our clients and, this approach is furthermore instilled within her leadership values.
Biljana has significant experience in North America, as the Director of operations at The Pediatric Early Phase-Clinical Trial Network (PEP-CTN). This is a consortium comprised of 21 premier Children Oncology Group (COG) pediatric core member sites across the USA and Canada.